These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12572286)

  • 1. [Thioridazine and the warning about prolonged QT time].
    Laisalmi M
    Duodecim; 2002; 118(24):2518. PubMed ID: 12572286
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic medications and cardiac conduction risks.
    Roman M; Farmer SY
    Issues Ment Health Nurs; 2010 Jan; 31(1):68-70. PubMed ID: 19951166
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiotoxicity and prescription of thioridazine in New Zealand.
    Menkes DB; Knight JC
    Aust N Z J Psychiatry; 2002 Aug; 36(4):492-8. PubMed ID: 12169148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Thioridazine: re-evaluating the risk/benefit equation.
    Timell AM
    Ann Clin Psychiatry; 2003 Jun; 15(2):131. PubMed ID: 12938870
    [No Abstract]   [Full Text] [Related]  

  • 5. The prolongation of QTc-interval by thioridazine.
    Sachdev P
    Aust N Z J Psychiatry; 2001 Dec; 35(6):857-8. PubMed ID: 11990903
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnesium homeostasis and antipsychotic-induced QTc prolongation.
    Meenagh C; Mulholland C; Ryan MF
    J Psychopharmacol; 2004 Sep; 18(3):438-9. PubMed ID: 15358992
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antipsychotic agents and the heart].
    Huttunen MO
    Duodecim; 2002; 118(15):1579. PubMed ID: 12244632
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.
    Salih IS; Thanacoody RH; McKay GA; Thomas SH
    Clin Pharmacol Ther; 2007 Nov; 82(5):548-54. PubMed ID: 17410120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioridazine (Mellaril) and mesoridazine (Serentil): prolongation of the QTc interval.
    Dallaire S
    CMAJ; 2001 Jan; 164(1):91, 95. PubMed ID: 11202679
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis.
    Wright NM; Roberts AJ; Allgar VL; Tompkins CN; Greenwood DC; Laurence G
    Br J Gen Pract; 2004 May; 54(502):370-3. PubMed ID: 15113522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSM thioridazine advice.
    Driscoll P
    Br J Gen Pract; 2004 Aug; 54(505):623; author reply 623-4. PubMed ID: 15296568
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychotropic drugs and the risk of arrhythmias].
    Toivonen L
    Duodecim; 2002; 118(12):1223-4. PubMed ID: 12239813
    [No Abstract]   [Full Text] [Related]  

  • 13. An incorrect diagnosis of psychosis?
    Bird S
    Aust Fam Physician; 2007 Apr; 36(4):267-8. PubMed ID: 17392943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Finzel M; Fric M; Laux G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Repercussions of the withdrawal of thioridazine].
    Buj Alvarez I; Pifarré Paredero J; Idini E; Puigdevall Ruestes M
    Actas Esp Psiquiatr; 2008; 36(3):183-6. PubMed ID: 18478459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic use in a patient with a prolonged QTc interval.
    Winter EC; Alessi LE
    Psychosomatics; 2008; 49(3):272-3. PubMed ID: 18448786
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psychopharmacological therapy of psychoses. 5. Thymoneuroleptic agents].
    Hertrich O
    Fortschr Med; 1972 Oct; 90(29):1069-72. PubMed ID: 4144505
    [No Abstract]   [Full Text] [Related]  

  • 18. Two cases of amisulpride overdose: a cause for prolonged QT syndrome.
    Ward DI
    Emerg Med Australas; 2005 Jun; 17(3):274-6. PubMed ID: 15953230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo treatment-resistant psychosis following thioridazine withdrawal.
    Bastiampillai T; Fantasia R; Nelson A
    Aust N Z J Psychiatry; 2014 Jun; 48(6):585-6. PubMed ID: 23908310
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort.
    Purhonen M; Koponen H; Tiihonen J; Tanskanen A
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1227-31. PubMed ID: 22941581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.